Personal Cfo Solutions, LLC Biocryst Pharmaceuticals Inc Transaction History

Personal Cfo Solutions, LLC

$557 Million
Q3 2025

A detailed history of Personal Cfo Solutions, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 62,188 shares of BCRX stock, worth $440,291. This represents 0.08% of its overall portfolio holdings.

Number of Shares

62,188

Previous 62,188 -0.0%

Holding current value

$440,291

Previous $466,000 1.29%

% of portfolio

0.08%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$7.06 - $9.39 $4,744 - $6,310	672 Added 1.09%	62,188 $466,000
Q4 2024 Feb 07, 2025	SELL	$7.03 - $8.43 $1,511 - $1,812	-215 Reduced 0.35%	61,516 $462,000
Q2 2024 Aug 09, 2024	SELL	$4.13 - $6.79 $20,650 - $33,950	-5,000 Reduced 7.49%	61,731 $381,000
Q1 2024 May 13, 2024	BUY	$4.89 - $7.65 $2,092 - $3,274	428 Added 0.65%	66,731 $338,000
Q4 2023 Feb 13, 2024	SELL	$4.98 - $6.77 $2,255 - $3,066	-453 Reduced 0.68%	66,303 $397,000

Q2 2023 Aug 10, 2023	SELL	$6.96 - $8.81 $6,960 - $8,810	-1,000 Reduced 1.48%	66,756 $469,000
Q1 2023 May 09, 2023	BUY	$7.94 - $11.84 $2,906 - $4,333	366 Added 0.54%	67,756 $565,000
Q3 2022 Nov 01, 2022	BUY	$10.79 - $14.81 $3,258 - $4,472	302 Added 0.45%	67,390 $849,000
Q2 2022 Aug 05, 2022	SELL	$7.89 - $17.88 $332,169 - $752,748	-42,100 Reduced 38.56%	67,088 $710,000
Q3 2021 Nov 18, 2021	SELL	$14.21 - $17.65 $35,382 - $43,948	-2,490 Reduced 2.23%	109,188 $1.57 Million
Q2 2021 Jul 22, 2021	SELL	$9.5 - $17.24 $95,000 - $172,399	-10,000 Reduced 8.22%	111,678 $1.77 Million
Q1 2021 Apr 21, 2021	BUY	$7.37 - $13.61 $121,605 - $224,565	16,500 Added 15.69%	121,678 $1.24 Million
Q4 2020 Feb 09, 2021	BUY	$3.37 - $8.61 $47,180 - $120,539	14,000 Added 15.35%	105,178 $783,000
Q3 2020 Nov 02, 2020	BUY	$3.43 - $5.53 $29,155 - $47,005	8,500 Added 10.28%	91,178 $0
Q2 2020 Aug 03, 2020	SELL	$1.9 - $5.61 $8,360 - $24,684	-4,400 Reduced 5.05%	82,678 $394,000
Q1 2020 Apr 30, 2020	BUY	$1.6 - $4.11 $88,124 - $226,370	55,078 Added 172.12%	87,078 $174,000
Q4 2019 Feb 13, 2020	BUY	$1.59 - $3.45 $50,880 - $110,400	32,000 New	32,000 $110,000

Others Institutions Holding BCRX

# of Institutions

310

Shares Held

200M

Call Options Held

640K

Put Options Held

507K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.32B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account

Personal Cfo Solutions, LLC Biocryst Pharmaceuticals Inc Transaction History